Keyphrases
Sepsis
100%
Disseminated Intravascular Coagulation
100%
Post-marketing Surveillance
100%
Thrombomodulin
100%
Surveillance Data
100%
Survival Rate
27%
Systemic Inflammatory Response Syndrome
18%
Adverse Drug Reaction
18%
Inflammation Markers
18%
Japanese Association for Acute Medicine
18%
Sequential Organ Failure Assessment
18%
Coagulation Markers
18%
Underlying Disease
9%
C-reactive Protein
9%
Bleeding
9%
Phase II Study
9%
Anticoagulants
9%
Antibody Test
9%
Antithrombin
9%
Bleeding Adverse Events
9%
Combined Administration
9%
Prothrombin Time
9%
Fibrinogen Degradation Products
9%
Serious Bleeding
9%
Time Ratio
9%
Resolution Rate
9%
Heparin Therapy
9%
Infectious Focus
9%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
100%
Postmarketing Surveillance
100%
Disseminated Intravascular Clotting
100%
Recombinant Thrombomodulin
100%
Survival Rate
27%
Inflammation
18%
Adverse Drug Reaction
18%
Organ Dysfunction Score
18%
Single Isomorphous Replacement
18%
Disease
9%
Adverse Event
9%
C Reactive Protein
9%
Anticoagulant Agent
9%
Heparin
9%
Prothrombin
9%
Fibrin Degradation Product
9%
Thrombin Antithrombin Complex
9%